Medical Research News

RSS

Why doctors say measles isn’t just back, it’s a warning sign for us all

A new editorial outlines the alarming resurgence of measles in the U.S., with over 880 cases reported by April 2025, largely driven by domestic transmission and declining vaccination coverage. The authors warn that without urgent public health action, measles could become endemic again, exposing broader vulnerabilities in vaccine-preventable disease defenses.

17 Jun 2025

What 300 grams of ultra-processed food a day does to your diabetes risk

A dose-response meta-analysis of 12 cohort studies finds that higher intake of ultra-processed foods (UPFs) is linked to a significantly increased risk of type 2 diabetes (T2D). The association remains even after adjusting for BMI, diet quality, and energy intake, with a steeper risk increase above 300 g/day.

17 Jun 2025

Rare pancreatic cancer patients show remarkable outcomes with immunotherapy

A new research paper was published in Volume 16 of Oncotarget on June 10, 2025, titled "Exceptional responders to immunotherapy in pancreatic cancer: A multi-institutional case series of a rare occurrence."

17 Jun 2025

Disrupted biological rhythms in teens can produce unexpected brain effects

A new McGill University-led study suggests that disrupting the body's internal clock during adolescence can alter how the brain responds to an in-utero risk factor linked to certain brain disorders.

17 Jun 2025

Living near algal blooms linked to faster ALS progression

Living close to cyanobacterial harmful algal blooms - which are present nationwide but are more common in coastal and Great Lake states - heightens the rate of dying from amyotrophic lateral sclerosis, or ALS, a study suggests.

17 Jun 2025

FDA-approved drug may help restore breathing in obesity-related sleep disorder

Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may offer a pathway for treating a life-threatening form of sleep-disordered breathing called Obesity Hypoventilation Syndrome.

17 Jun 2025

Bariatric surgery linked to lower risk of psychiatric disorders than GLP-1 drugs

People who have metabolic and bariatric surgery are significantly less likely to develop psychiatric disorders compared to those who take weekly injections of GLP-1 anti-obesity medications, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Bariatric surgery leads to greater weight loss than GLP-1 drugs after two years

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, according to a new head-to-head real-world study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

Minor complication rates higher among Black patients after bariatric procedures

Black patients are more likely to experience minor complications after metabolic and bariatric surgery than White patients, according to new study presented today at the American Society for Metabolic and Bariatric Surgery 2025 Annual Scientific Meeting.

17 Jun 2025

Higher BMI linked to increased risk of complications after bariatric surgery

The higher a person's body mass index (BMI), the higher their risk for complications after bariatric surgery, especially those with BMI of 50 or more, according to a new study presented today at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.

17 Jun 2025

PDE3 inhibitors show promise in promoting bone growth

Bone growth occurs through the proliferation of specialized cells of the cartilage tissue, known as chondrocytes, on either end of a bone.

17 Jun 2025

Aging family physician workforce challenges primary care in Ontario

A new ICES study has found that 1.74 million patients in Ontario are attached to family physicians aged 65 or older, and that many of those patients are elderly and have complex medical needs.

17 Jun 2025

Could a diabetes drug be the key to stopping Alzheimer’s?

Investigating tirzepatide's role in Alzheimer's reveals its potential to improve brain function and reduce inflammation, linking diabetes and neurodegeneration.

17 Jun 2025

Understanding long-term challenges for older breast cancer survivors

Lead author Claire Morton, MD, and senior author Christina Ahn Minami, MD, MS, both of the Department of Surgery at Brigham and Women's Hospital, published a paper in Current Breast Cancer Reports "Survivorship Issues in Older Adults with Breast Cancer.

17 Jun 2025

Healthy glial cell transplants slow Huntington’s disease progression

Huntington's disease has long defied attempts to rescue suffering neurons. A new study in Cell Reports shows that transplanting healthy human glial progenitor cells into the brains of adult animal models of the disease not only slowed motor and cognitive decline but also extended lifespan.

17 Jun 2025

Qureight's synthetic study arms validate clinical efficacy in pioneering rare lung disease treatment

Qureight, a deep-learning analytics company accelerating drug development through AI-powered data curation, today announced that its digitally-twinned synthetic control arm has been used in a breakthrough clinical trial application in place of a human placebo group, marking a world-first in lung disease research.

17 Jun 2025

Mursla Bio introduces AI Precision Medicine Platform built on organ-specific EV isolation from blood

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve cancer outcomes for at-risk patients, today announced the commercial launch of its AI Precision Medicine Platform, alongside a pre-print reporting the first validated method for isolating hepatocyte EVs from plasma for organ-specific proteomic and miRNA profiling. Mursla Bio is engaging with potential partners to apply its Platform to additional disease areas, biomarker discovery and IV

17 Jun 2025

Sphere Bio expands operations in China

Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today announced the appointment of Redbert Biotechnology (张伟) as its exclusive distribution partner in China.

17 Jun 2025

Evosep joins P4ML to power world’s largest multi-omic human health study of two million samples

Evosep, a global leader in robust, high-throughput proteomics technologies, has been selected as the proteomics platform provider for the P4ML - OMICAssist Study—the world's largest multi-omic precision medicine initiative, launched by P4ML alongside its strategic academic, health regulatory, and semi-state partners in the United Arab Emirates.

From Evosep 17 Jun 2025

Wayne State researchers investigate PFAS impact on male fertility

A new grant from the National Institutes of Health (NIH) will help Wayne State University researchers explore potential connections between per- and polyfluoroalkyl substances (PFAS) exposure and adverse effects on male reproductive health.

17 Jun 2025